A number of lipophilic N-acyl-diamines and aldonamides have been synthesized and tested for their in vitro antiproliferative activity against Leishmania amazonensis and L. chagasi. Ribonamides, having one amino group, displayed good to moderate inhibition of parasite growth. The best result was obtained for compounds 10 and 15 with IC 50 against L. chagasi below 5 µ µ µ µM.
INTRODUCTION
Leishmaniasis is caused by a species belonging to the genus Leishmania, a protozoan parasite spread by the bite of infected phlebotomine sand flies. The disease currently affects about 350 million people in 88 countries around the world [1] . The three main clinical syndromes are cutaneous leishmaniasis, mucocutaneous leishmaniasis, and visceral leishmaniasis (also known as kala-azar), which is fatal if untreated. In the last years, cases of HIV and visceral leishmaniasis coinfection have also been reported in 35 countries [2] .
The current chemotherapeutic treatment for human leishmaniasis relies on a few drugs, such as pentavalent antimonials (pentostam and glucantime), amphotericin B, and more recently miltefosine [3] . The treatment is limited by cost, difficulty of administration, variability of the efficacy, toxicity, and emergence of resistant strains [4, 5, 6] . There is, thus, an urgent need for the development of novel, nontoxic, potent, and effective new treatments for this worldwide health problem.
Among the number of compounds tested in the last years against Leishmania, several lipophilic diamine derivatives have been described [7, 8, 9, 10] . Polyamines, such as putrescine, spermidine, and spermine, are essential for cellular growth and proliferation in all living organisms. The antileishmanial activity of lipophilic diamines would be due to their interference with the polyamine metabolism pathway of the protozoa, different from the mammalian cells polyamine pathway [11, 12, 13] . The lipophilic part of the molecule facilitates its interaction with membrane lipids, allowing its penetration into the cytoplasm where it can act [14, 15] .
In this work, we report the synthesis and antileishmanial activity of two types of aldonamides derived from lipophilic diamines and N-acylated diamines (Fig. 1) . 
MATERIAL AND METHODS

Chemicals
Preparation of aldonamides 9-16 was achieved by the nucleophilic addition of N-alkylamines 1-8 to Dribono-1,4-lactone (Scheme 1) [9, 16, 17] . N-Acylated diamines 22-31 were prepared by reaction of fatty esters 17-21 with either 1,2-ethanediamine or 1,4-butanediamine [18, 19] . Reaction of the resultant amides with D-glucono-1,5-lactone led to aldonamides 32-41 (Scheme 1) [20] . SCHEME 1. Synthesis of potential antileishmanial compounds.
In vitro Evaluation
The antiproliferative activity of compounds 9-16 and 22-41 against L. amazonensis and L. chagasi was determined in vitro by the colorimetric MTT method based on tetrazolium salt reduction by mitochondrial dehydrogenases, as previously described [3, 9] . The results are expressed as the concentrations inhibiting parasite growth by 50% (IC 50 ) after a 3-day incubation period. The IC 50 values represent means of three separate experiments. Amphotericin B was used as the reference drug and IC 50 values were of 0.9 and 1.9 µM on L. amazonensis and L. chagasi promastigote forms, respectively.
RESULTS AND DISCUSSION
The results are presented in Table 1 . All ribonamides 9-16 displayed good to moderate activity against the two species of Leishmania. Compounds 10 and 15 were the most active against L. chagasi (IC 50 = 2.49 µM) and L. amazonensis (IC 50 =11.8 µM), respectively. Interestingly, in a general biological evaluation, the compounds tested were more active against the promastigote form of L. chagasi, the causal agent of fatal visceral leishmaniasis. Hydrosolubility seems to be important, as glycosylated compounds 9-16, having a polar moiety, are more active than amides 22-31. However, the antileishmanial activity of the ribonamides remains lower than that of the corresponding diamines 1-8 [9] .
None of the tested gluconamides exibited antiproliferative activity. These compounds possess two amide groups in their structure, while in compounds 9-16, only one of the nitrogen atoms is involved in an amide linkage. This suggests that the presence of at least one amine group is of great importance in the mechanism of action of these compounds against Leishmania.
In the N-acyl-diamine series, compound 30, having a 12-carbon chain, was the only N-acylated butanediamine derivative showing activity. These compounds appeared to be less soluble than their ethylenediamine analogues, complicating the tests. Short-chain compounds 22, 23, 27, and 28 were inactive. The best results were obtained for compounds 26 and 30, which displayed moderated antiproliferative activity against the two species of Leishmania.
CONCLUSION
In this work, we described the preparation and antileishmanial evaluation of three series of amides derived from lipophilic diamines. The best results were obtained with ribonamides 10 and 15, showing that the presence of a polar group, enhancing the hydrosolubility of the compound, may be important. The results also showed that the presence of at least one amine group is necessary for the antiproliferative activity. 
